Skip to content

Clinical trials

Phase 1/2 Retinitis Pigmentosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 1/2 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20121
20141
20153
20181
20192
20202
20222
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ProQR Therapeutics2
AbbVie1
Allergan1
Bionic Sight LLC1
BlueRock Therapeutics1
Endogena Therapeutics, Inc1
GenSight Biologics1
National Center for Complementary and Integrative Health (NCCIH)1
National Eye Institute (NEI)1
Octant, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa18
Eye Diseases6
Cone-Rod Dystrophies3
Eye Diseases, Hereditary3
Retinal Degeneration3
Retinal Diseases3
Usher Syndromes3
Retinal Dystrophies2
Vision Disorders2
Eye Abnormalities1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.